Literature DB >> 33374239

Selenomethionine (Se-Met) Induces the Cystine/Glutamate Exchanger SLC7A11 in Cultured Human Retinal Pigment Epithelial (RPE) Cells: Implications for Antioxidant Therapy in Aging Retina.

Sudha Ananth1, Seiji Miyauchi1, Muthusamy Thangaraju1, Ravirajsinh N Jadeja1,2, Manuela Bartoli2,3, Vadivel Ganapathy4, Pamela M Martin1,2,3,5.   

Abstract

Oxidative damage has been identified as a major causative factor in degenerative diseases of the retina; retinal pigment epithelial (RPE) cells are at high risk. Hence, identifying novel strategies for increasing the antioxidant capacity of RPE cells, the purpose of this study, is important. Specifically, we evaluated the influence of selenium in the form of selenomethionine (Se-Met) in cultured RPE cells on system xc- expression and functional activity and on cellular levels of glutathione, a major cellular antioxidant. ARPE-19 and mouse RPE cells were cultured with and without selenomethionine (Se-Met), the principal form of selenium in the diet. Promoter activity assay, uptake assay, RT-PCR, northern and western blots, and immunofluorescence were used to analyze the expression of xc-, Nrf2, and its target genes. Se-Met activated Nrf2 and induced the expression and function of xc- in RPE. Other target genes of Nrf2 were also induced. System xc- consists of two subunits, and Se-Met induced the subunit responsible for transport activity (SLC7A11). Selenocysteine also induced xc- but with less potency. The effect of Se-met on xc- was associated with an increase in maximal velocity and an increase in substrate affinity. Se-Met increased the cellular levels of glutathione in the control, an oxidatively stressed RPE. The Se-Met effect was selective; under identical conditions, taurine transport was not affected and Na+-coupled glutamate transport was inhibited. This study demonstrates that Se-Met enhances the antioxidant capacity of RPE by inducing the transporter xc- with a consequent increase in glutathione.

Entities:  

Keywords:  SLC7A11; age-related macular degeneration (AMD), antioxidants; glutathione; oxidative stress; retina; retinal pigment epithelium (RPE); selenium; selenomethionine (Se-Met); system xc; xCT

Year:  2020        PMID: 33374239      PMCID: PMC7823377          DOI: 10.3390/antiox10010009

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  60 in total

1.  The putative therapeutic value of high-dose selenium in proliferative retinopathies may reflect down-regulation of VEGF production by the hypoxic retina.

Authors:  M F McCarty
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

Review 2.  Mechanisms of age-related macular degeneration and therapeutic opportunities.

Authors:  Menno van Lookeren Campagne; Jennifer LeCouter; Brian L Yaspan; Weilan Ye
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

3.  System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.

Authors:  Richard J Bridges; Nicholas R Natale; Sarjubhai A Patel
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture.

Authors:  Carolin S Hoefig; Kostja Renko; Josef Köhrle; Marc Birringer; Lutz Schomburg
Journal:  J Nutr Biochem       Date:  2010-12-28       Impact factor: 6.048

5.  Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling.

Authors:  N M Reddy; S R Kleeberger; J H Bream; P G Fallon; T W Kensler; M Yamamoto; S P Reddy
Journal:  Oncogene       Date:  2008-06-09       Impact factor: 9.867

6.  Selenomethionine regulation of p53 by a ref1-dependent redox mechanism.

Authors:  Young R Seo; Mark R Kelley; Martin L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-30       Impact factor: 11.205

7.  Effects of hyperglycemia and oxidative stress on the glutamate transporters GLAST and system xc- in mouse retinal Müller glial cells.

Authors:  Barbara Mysona; Ying Dun; Jennifer Duplantier; Vadivel Ganapathy; Sylvia B Smith
Journal:  Cell Tissue Res       Date:  2009-01-21       Impact factor: 5.249

Review 8.  Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment.

Authors:  Valentina Gandin; Prajakta Khalkar; Jeremy Braude; Aristi P Fernandes
Journal:  Free Radic Biol Med       Date:  2018-05-08       Impact factor: 7.376

Review 9.  Involvement of Nrf2 in Ocular Diseases.

Authors:  Shehzad Batliwala; Christy Xavier; Yang Liu; Hongli Wu; Iok-Hou Pang
Journal:  Oxid Med Cell Longev       Date:  2017-03-27       Impact factor: 6.543

Review 10.  Selenium Anticancer Properties and Impact on Cellular Redox Status.

Authors:  Lolita Kuršvietienė; Aušra Mongirdienė; Jurga Bernatonienė; Jurgita Šulinskienė; Inga Stanevičienė
Journal:  Antioxidants (Basel)       Date:  2020-01-17
View more
  3 in total

1.  Ferroptosis and Apoptosis Are Involved in the Formation of L-Selenomethionine-Induced Ocular Defects in Zebrafish Embryos.

Authors:  Meng Gao; Jun Hu; Yuejie Zhu; Xianqing Wang; Shumin Zeng; Yijiang Hong; Guang Zhao
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

2.  Oxidative Stress and Inflammation in Retinal Degeneration.

Authors:  Ravirajsinh N Jadeja; Pamela M Martin
Journal:  Antioxidants (Basel)       Date:  2021-05-17

3.  Selenomethionine Ameliorates Cognitive Impairment, Decreases Hippocampal Oxidative Stress and Attenuates Dysbiosis in D-Galactose-Treated Mice.

Authors:  Ying Gao; Yongquan Xu; Junfeng Yin
Journal:  Antioxidants (Basel)       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.